Top Story

FDA approves fixed-dose combination for patients with hypertension

January 26, 2015

Symplmed Pharmaceuticals announced that the FDA has approved the fixed-dose combination of perindopril arginine and amlodipine for the treatment of hypertension in patients whose BP is not adequately controlled on monotherapy.

In the event that a patient is likely to require treatment with multiple drugs to achieve target BP, the fixed-dose combination can also be used as initial therapy, according to a press release.

FDA News

FDA accepts alirocumab for priority review

January 26, 2015
Sanofi and Regeneron announced that the FDA has accepted the companies’ Biologics License Application for the proprotein convertase subtilisin/kexin type 9…
In the Journals

Majority of PCPs assigned high value to medical imaging

January 26, 2015
The majority of primary care physicians considered access to medical imaging to be essential to patient care, indicating that it aided in establishing earlier and more…
Martin B. Leon, MD 5 Questions with Dr. Bhatt

A Conversation with Martin B. Leon, MD

Cardiology Today's Intervention, January/February 2015
For this issue, Dr. Bhatt talks with Martin B. Leon, MD, professor of medicine at Columbia University Medical Center, director of the Center for Interventional Vascular…
Cross-Pollination: The Catalytic Impact of CTO Interventions CTO Corner

Cross-Pollination: The Catalytic Impact of CTO Interventions

Cardiology Today's Intervention, January/February 2015
Emmanouil S. Brilakis, MD, PhD
Cross-pollination is the process by which pollen is transferred from the anther, or male part, of one plant to the stigma, or female part, of another plant, thereby…
More News Headlines »
CME
Experts Take: Dialogue on HTG

Experts’ Take: Dialogue on Hypertriglyceridemia

This activity is supported by an independent educational grant from Amarin Pharma Inc.

Lead by genetic studies, recent data describe a causal role of triglycerides (TG) in the formation of atherosclerosis…
More »
Meeting News Coverage Video
thumbnail for video 3945938325001

Kirk N. Garratt, MD: Prolonged DAPT beneficial in patients with paclitaxel-eluting stents

December 16, 2014
CHICAGO — In this video, Kirk N. Garratt, MD, of the Lennox Hill Hospital, New York, outlines results of a study…
More »
CME
Individualizing T2DM Treatment: Determining Optimal Pathways That Lead to Achieving Target Goals

Individualizing T2DM Treatment: Determining Optimal Pathways That Lead to Achieving Target Goals

This activity is supported by educational grants from Lilly USA, LLC and Novo Nordisk.

The prevalence of type 2 diabetes mellitus has escalated in recent years and targeting treatmentcontinues to be a…
More »
morganatic-roan morganatic-roan